STOCK TITAN

Cyber Attack on Evotec

Rhea-AI Impact
(Neutral)
Rhea-AI Sentiment
(Neutral)
Tags

HAMBURG, GERMANY / ACCESSWIRE / April 7, 2023 / Evotec SE (Frankfurt Stock Exchange: EVT, MDAX/TecDAX, ISIN:DE 000 566480 9, WKN 566480; NASDAQ:EVO) announces that on 06 April, 2023 a cyber attack occurred on Evotec‘s IT systems. As a result, the systems were shut down proactively and disconnected from the Internet to secure from data corruption or breaches. The IT systems are currently being examined and the scope of the impact is being reviewed. Highest diligence will be applied to data integrity.

- End of the ad hoc release -

Contact: Dr Werner Lanthaler, Chief Executive Officer, Evotec SE, Manfred Eigen Campus, Essener Bogen 7, 22419 Hamburg, Germany, Phone: +49.(0)40.560 81-242, Email: werner.lanthaler@evotec.com

End of Inside Information

SOURCE: Evotec SE


Evotec SE, Friday, April 7, 2023, Press release picture



View source version on accesswire.com:
https://www.accesswire.com/748118/Cyber-Attack-on-Evotec

Evotec SE

NASDAQ:EVO

EVO Rankings

EVO Latest News

EVO Stock Data

Pharmaceutical Preparation Manufacturing
Manufacturing
Link
Miscellaneous, Investment Trusts/Mutual Funds
Germany
Hamburg

About EVO

Evotec SE is a publicly listed drug discovery and development company headquartered in Hamburg, Germany. The company operates globally, largely through external alliances with pharmaceutical and biotechnology companies, academic institutions, patient advocacy groups, and venture capitalists.